We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Wearable Cardiac Monitor with Cellular Transmission Enhances Remote Arrhythmia Detection

By HospiMedica International staff writers
Posted on 27 Apr 2026

Remote cardiac monitoring requires comfort, wearability, and adherence to gather electrocardiogram data for clinical review. More...

Mailing devices back for data processing can delay review. Faster insights, greater comfort, and seamless connectivity are key aims for programs that manage cardiac rhythm remotely. A new device now offers built-in cellular transmission, a waterproof design, and longer battery life to support faster insights and a more comfortable monitoring experience.

RhythMedix, LLC (Mount Laurel, NJ, USA) has launched the next-generation RhythmStar SL cardiac monitoring wearable. The third-generation design enhances the patient experience by improving comfort, wearability, and adherence. These updates are enabled by a compact lead configuration, a waterproof IPX-6 rating, and increased battery life.

RhythmStar features built-in cellular connectivity that automatically transmits electrocardiogram (ECG) data to the cloud for prompt review across all monitoring modes. Because data are processed without requiring device return by mail, review can occur promptly and seamlessly. When paired with the company’s proprietary Augmented Arrhythmia Intelligence (AAI), the system delivers precise arrhythmia detection by combining advanced algorithms with a multi-layered data review process.

RhythMedix, a nationwide U.S.-based cardiac monitoring company, reports more than 2 million hearts monitored to date. The technology is described as designed to improve both patient adherence and clinical workflow. The company will be exhibiting at HRS 2026 (Booth #531), including in-booth discussions with leading electrophysiologists.

“RhythmStar represents our commitment to delivering a better way to monitor, one that prioritizes both patient comfort and clinical performance. By combining a more wearable design with seamless data transmission and expert review, we're helping clinicians access the insights they need, when they need them,” said Brian Pike, CEO of RhythMedix.

“RhythMedix is taking a truly visionary approach to cardiac monitoring by combining patient-friendly design with advanced technology and expert oversight, helping clinicians make more confident, timely decisions. It's a meaningful step forward in how we deliver and manage cardiac care,” stated George Shaw, MD, Electrophysiologist at AHN Allegheny Health Network.

Related Links
RhythMedix 


Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Monitor/Defibrillator
Zenix
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.